English
Back
Download
Log in to access Online Inquiry
Back to the Top

News

$Pulse Biosciences (PLSE.US)$ Reuters · just 1min.                                                   Pulse Biosciences, Inc. Announces Receipt of FDA Breakthrough Device Designation for Cellfx® Nspfa Cardiac Surgery System for the Treatment of Atrial Fibrillation
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
Translate
Report
17K Views
Comment
Sign in to post a comment
    5227
    Followers
    23
    Following
    75K
    Visitors
    Follow
    Reassessing Chinese Assets
    Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.